Coherus Oncology, Inc. (CHRS) Dividend Yield, History & Forecast
Coherus Oncology, Inc. (CHRS) is a Biotechnology company in the Healthcare sector listed on the NASDAQ Global Market. market capitalization is approximately $203M.
Frequently Asked Questions about Coherus Oncology, Inc. (CHRS)
Is Coherus Oncology, Inc. a Dividend Aristocrat?▾
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is Coherus Oncology, Inc. in?▾
Coherus Oncology, Inc. (CHRS) operates in the Healthcare sector, specifically the Biotechnology industry.
